Table 1.
COVID‐19 | CONTROL | Group with COVID‐19 showed | Unpaired t‐test (two‐tailed P value) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Mean | SD | 99% CI | n | Mean | SD | 99% CI | |||||
p50 using Eq. 1, mmHg | 3518 | 23·37 | 3·13 | 23·23 | 23·50 | 15 945 | 24·59 | 5·42 | 24·48 | 24·70 | Lower p50 | <0·0001 |
p50 using Eq. 2, mmHg | 3518 | 24·8 | 3·7 | 24·7 | 25·0 | 15 945 | 25·7 | 6·0 | 25·6 | 25·8 | Lower p50 | <0·0001 |
pH | 3518 | 7·382 | 0·077 | 7·379 | 7·386 | 15 932 | 7·397 | 0·072 | 7·395 | 7·398 | Lower pH | <0·0001 |
pO2, mmHg | 3518 | 77·9 | 28·0 | 76·7 | 79·1 | 15 945 | 86·6 | 62·5 | 85·3 | 87·8 | Lower pO2 | <0·0001 |
SO2, % | 3518 | 94·2 | 7·9 | 93·9 | 94·6 | 15 945 | 93·1 | 10·4 | 92·9 | 93·3 | Higher SO2 | <0·0001 |
pCO2, mmHg | 3518 | 46·1 | 11·8 | 45·5 | 46·6 | 15 936 | 43·1 | 10·1 | 42·9 | 43·4 | Higher pCO2 | <0·0001 |
BE, mmol/l | 3518 | 1·2 | 4·3 | 1·0 | 1·3 | 15 925 | 0·7 | 4·2 | 0·6 | 0·8 | Higher BE | <0·0001 |
Hct, % | 3483 | 26·5 | 4·0 | 26·4 | 26·7 | 15 703 | 29·7 | 6·7 | 29·6 | 29·8 | Lower Hct | <0·0001 |
Hb, g/l | 3518 | 81·2 | 12·4 | 80·6 | 81·7 | 15 941 | 93·8 | 20·2 | 93·4 | 94·2 | Lower Hb | <0·0001 |
PaO2/FiO2, mmHg | 2627 | 215·7 | 111·5 | 210·1 | 221·3 | 13,941 | 299·4 | 236·5 | 294·2 | 304·6 | Lower PaO2/FiO2 | <0·0001 |
Temperature, °C | 3518 | 36·8 | 0·8 | 36·8 | 36·8 | 15 945 | 36·8 | 0·8 | 36·8 | 36·8 | NS | 0·057 |
BE, base excess; Hct, haematocrit; NS, no significant difference.
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.